Valuation: BioElectronics Corporation

Market Cap 12.35M 10.7M 10.1M 9.16M 17.19M 1.18B 17.31M 121M 46.49M 601M 46.39M 45.37M 1.91B P/E 2020
-26.5x
P/E 2021 -95.5x
Enterprise Value 25.69M 22.26M 21.01M 19.06M 35.76M 2.46B 36.02M 251M 96.69M 1.25B 96.5M 94.38M 3.97B EV / Sales 2020
53.6x
EV / Sales 2021 24.2x
Free-Float
100%
Yield 2020 *
-
Yield 2021 -
1 week+14.29%
Current month+48.15%
1 month+33.33%
3 months+14.29%
1 week 0
Extreme 0.0003
0
1 month 0
Extreme 0.0002
0
Current year 0
Extreme 0.0002
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 0.0001
0
5 years 0
Extreme 0.0001
0
10 years 0
Extreme 0.0001
0.01
Manager TitleAgeSince
Chief Executive Officer - 15/11/2019
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 85 15/06/2020
Director/Board Member - 15/11/2019
Director/Board Member - 03/12/2024
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+14.29%+100.00%0.00% 8.65M
+0.62%-0.03%+27.98%+20.11% 225B
+1.55%-2.12%+6.95%-19.49% 141B
+2.38%+3.07%-15.95%+24.86% 130B
+4.82%-5.75%-56.14%-15.32% 62.29B
+1.99%-0.03%-18.12%-12.87% 49.39B
+1.36%-4.87%+10.25%+16.88% 48.63B
-0.09%-2.69%+19.12%+29.42% 41.42B
+0.41%+0.15%+38.80%+53.43% 40.12B
+2.16%-2.35%-17.45%+52.38% 31.23B
Average +1.56%-2.91%+9.54%+14.94% 76.97B
Weighted average by Cap. +1.62%-2.40%+4.05%+12.03%

Financials

2020 2021
Net sales 830K 719K 678K 615K 1.15M 79.51M 1.16M 8.1M 3.12M 40.34M 3.12M 3.05M 128M 1.61M 1.39M 1.32M 1.19M 2.24M 154M 2.26M 15.72M 6.06M 78.26M 6.04M 5.91M 249M
Net income -1.16M -1M -948K -860K -1.61M -111M -1.63M -11.33M -4.36M -56.39M -4.36M -4.26M -179M -290K -251K -237K -215K -403K -27.78M -406K -2.83M -1.09M -14.09M -1.09M -1.06M -44.8M
Net Debt 13.07M 11.32M 10.69M 9.69M 18.19M 1.25B 18.32M 128M 49.18M 635M 49.08M 48M 2.02B 13.34M 11.56M 10.91M 9.9M 18.57M 1.28B 18.7M 130M 50.21M 649M 50.11M 49.01M 2.06B
Logo BioElectronics Corporation
BioElectronics Corporation is an electroceutical company, which develops wearable, neuromodulation devices to safely mitigate neurological diseases. Its pulsed shortwave therapy technology (PSWT) uses low-power pulsed electromagnetic fields to regulate electrical activity of the nervous system. The Company’s product line includes ActiPatch Musculoskeletal Pain Therapy, and RecoveryRx Post-operative and Chronic Wounds Therapy, which are sold by or on the order of medical professionals. PSWT is a non-invasive electromagnetic therapy designed to reduce pain and enhance life in patients with chronic musculoskeletal conditions. PSWT has no systemic side effects and can be self-administered at home. The ActiPatch product provides advanced long-lasting pain relief using Electromagnetic Pulse Therapy and works great for back pain, knee pain, muscle & joint pain, arthritis, sciatica, fibromyalgia, strains, sprains and more.
Employees
9
Date Price Change Volume
14/09/26 $0.000350 0.00% 2,842,500
11/09/26 $0.000350 +16.67% 434,000
10/09/26 $0.000300 0.00% 3,036,501
09/09/26 $0.000300 -14.29% 2,970,000
08/09/26 $0.000350 0.00% 3,186,084
  1. Stock Market
  2. Stocks
  3. BIEL Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!